SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness. (2019)

First Author: Nguyen CH
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-019-45579-0

PubMed Identifier: 31235852

Publication URI: http://europepmc.org/abstract/MED/31235852

Type: Journal Article/Review

Volume: 9

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322